Efficacy and toxicity of 2-Chlorodeoxyadenosine (Cladribine)--2 h infusion for 5 days--as first-line treatment for advanced low grade non-Hodgkin's lymphoma.

Fridrik, M A; Jäger, G; Kienzer, H R; Hausmaninger, H; Oppitz, P; Krieger, O; Zabernigg, A; Lang, A; Neubauer, M; Weidinger, G; Schiller, L; Seewann, H L; Chott, A; Linkesch, W

Fridrik, M A; Jäger, G; Kienzer, H R; Hausmaninger, H; Oppitz, P; Krieger, O; Zabernigg, A; Lang, A; Neubauer, M; Weidinger, G; Schiller, L; Seewann, H L; Chott, A; Linkesch, W.

Affiliation

Fridrik MA; First Department of Medicine, General Hospital, Linz, Austria.

Eur J Cancer ; 34(10): 1560-4, 1998 Sep.

Article in En | MEDLINE | ID: mdl-9893628

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Cladribine / Antineoplastic Agents Type of study: Clinical_trials / Observational_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur J Cancer Year: 1998 Document type: Article Affiliation country: Austria Country of publication: Reino Unido

Search on Google

Add to My VHL

XML

PubMed Links